1,444
Views
9
CrossRef citations to date
0
Altmetric
Neurology

The burden of multiple sclerosis in Japan

, , &
Pages 1290-1298 | Received 07 Jun 2017, Accepted 09 Aug 2017, Published online: 12 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kaoru Yamabe, Marco D DiBonaventura & Chris L Pashos. (2019) Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries. ClinicoEconomics and Outcomes Research 11, pages 61-71.
Read now

Articles from other publishers (8)

S. Dewilde, G. Phillips, S. Paci, F. De Ruyck, N. H. Tollenaar & M. F. Janssen. (2023) People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies. Advances in Therapy.
Crossref
Qian Jiang, Wenjun Wang, Wendong Chen & Yan Xu. (2023) The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study. Multiple Sclerosis and Related Disorders 73, pages 104626.
Crossref
Amir KhakbanElisabet Rodriguez Llorian, Kristina D. Michaux, Scott B. Patten, Anthony Traboulsee, Jiwon Oh & Larry D. Lynd. (2023) Direct Health Care Costs Associated With Multiple Sclerosis. Neurology 100:9.
Crossref
Remina Shirai & Junji Yamauchi. (2022) New Insights into Risk Genes and Their Candidates in Multiple Sclerosis. Neurology International 15:1, pages 24-39.
Crossref
Christopher Drudge, Melody Zhao, Satoru Tanaka, Nozomu Tanaka, Hiromichi Otaka, Izumi Kawachi, Dieter A. Häring, Róisín Brennan, Nicholas Adlard & Imtiaz A. Samjoo. (2022) Systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis. Clinical and Experimental Neuroimmunology 13:4, pages 234-245.
Crossref
Arielle Kasindi, Dieu-Trang Fuchs, Yosef Koronyo, Altan Rentsendorj, Keith Black & Maya Koronyo-Hamaoui. (2022) Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation. Cells 11:9, pages 1578.
Crossref
Ting Zhou, Haijing Guan, Luying Wang, Yao Zhang, Mingjun Rui & Aixia Ma. (2021) Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review. Frontiers in Public Health 9.
Crossref
Andrius Kavaliunas, Virginija Danylaite Karrenbauer & Jan Hillert. (2021) Socioeconomic consequences of multiple sclerosis—A systematic literature review. Acta Neurologica Scandinavica.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.